OncoMed Pharmaceuticals Inc Restructuring Charges
OncoMed Pharmaceuticals Inc reported Restructuring Charges of $1.85 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2019-03-07
- OncoMed Pharmaceuticals Inc restructuring charges for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- OncoMed Pharmaceuticals Inc restructuring charges for the quarter ending 2018-03-31 was $0.00.
- OncoMed Pharmaceuticals Inc restructuring charges for the quarter ending 2017-12-31 was $14.00K.
- OncoMed Pharmaceuticals Inc restructuring charges for the quarter ending 2017-09-30 was $69.00K.
- OncoMed Pharmaceuticals Inc restructuring charges for fiscal 2018 was $1.85M, a 26.75% decline from fiscal 2017.
- OncoMed Pharmaceuticals Inc restructuring charges for fiscal 2017 was $2.53M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 11 month | Restructuring Charges 12 month | Restructuring Charges 14 month |
|---|---|---|---|---|---|---|
| 2018-12-31 | $1.85M 10-K · filed 2019-03-07 | |||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $0.00 10-Q · filed 2018-08-02 | $14.00K derived: sum of 3 quarters · filed 2019-03-07 | $83.00K derived: sum of 4 quarters · filed 2019-03-07 | $2.50M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-08 | $14.00K derived: sum of 2 quarters · filed 2019-03-07 | $83.00K derived: sum of 3 quarters · filed 2019-03-07 | $2.50M 10-Q · filed 2018-05-08 | $2.53M derived: sum of 4 quarters · filed 2019-03-07 | |
| 2017-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $83.00K derived: sum of 2 quarters · filed 2019-03-07 | $2.53M derived: sum of 3 quarters · filed 2019-03-07 | $2.53M 10-K · filed 2019-03-07 | ||
| 2017-09-30 | $69.00K 10-Q · filed 2018-11-01 | $2.51M derived: sum of 2 quarters · filed 2018-11-01 | $2.51M 10-Q · filed 2018-11-01 | |||
| 2017-06-30 | $2.44M 10-Q · filed 2018-08-02 | $2.44M 10-Q · filed 2018-08-02 |